REDWOOD CITY, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company ...
Presentation to focus on use of validated pTau217 assay in participant screening process for Phase 2 ALTITUDE-AD study of sabirnetug for early Alzheimer’s disease - Late-breaking presentation to be ...
The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...